Nav: Home

Researcher receives NIH award to study pneumonia biology

January 25, 2017

(Boston) -- Joseph P. Mizgerd, ScD, professor of medicine at Boston University School of Medicine (BUSM), has received an Outstanding Investigator Award from the National Heart, Lung and Blood Institute at the National Institutes of Health. Dr. Mizgerd will use this seven-year, $5.9 million grant to study the biology of pneumonia.

With the grant Mizgerd and his research team plan to further advance the understanding of lung defense against pneumonia, generate new approaches to preventing and curing pneumonia and further the concept that pneumonia is a chronic disease of aging.

According to Mizgerd, pneumonia kills more children worldwide and hospitalizes more children in the United States than any other disease. The risk of death from pneumonia increases throughout adulthood, affecting older adults more than children. Pneumonia also accelerates unhealthy aging, including a rapid decline of chronic pulmonary diseases and cardiovascular diseases.

"We need to understand the lung defenses that normally prevent pneumonia in young, healthy adults before we can identify, prevent, or reverse what goes wrong to make individuals susceptible to pneumonia," Mizgerd said.

This is the first year that the NHLBI has provided Outstanding Investigator Awards, designed to support the research program of an investigator rather than one single research project. "It means a lot to me that the NHLBI provided such an award to a pneumonia researcher," Mizgerd said. "It demonstrates recognition of the terrible lung disease that pneumonia is, and a commitment to fighting respiratory infection by focusing on the lung rather than just the microbe."
-end-
About the National Heart, Lung and Blood Institute

The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.

About Boston University School of Medicine

Originally established in 1848 as the New England Female Medical College, and incorporated into Boston University in 1873, Boston University School of Medicine (BUSM) today is a leading academic medical center with an enrollment of more than 700 medical students and 950 students pursuing degrees in graduate medical sciences. BUSM faculty contribute to more than 668 active grants and contracts, with total anticipated awards valued at more than $693 million in amyloidosis, arthritis, cardiovascular disease, cancer, infectious diseases, pulmonary disease and dermatology, among other areas. The School's clinical affiliates include its primary teaching hospital Boston Medical Center, the Boston VA Healthcare System, Kaiser Permanente in northern California, as well as Boston HealthNet, a network of 15 community health centers. For more information, please visit http://www.bumc.bu.edu/busm/

Boston University Medical Center

Related Pneumonia Articles:

Bacteria in pneumonia attack using bleaching agent
Research shows that bacteria use hydrogen peroxide to weaken the immune system and cause pneumonia.
Many kids with pneumonia get unnecessary antibiotics, chest X-rays
Preschool children with community-acquired pneumonia often receive unnecessary tests and treatment at outpatient clinics and emergency departments, according to a nationally representative study led by Todd Florin, M.D., MSCE, from Ann & Robert H.
Certain psychiatric drugs linked with elevated pneumonia risk
A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.
Bacterial pneumonia far more dangerous to the heart than viral pneumonia, study finds
Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research.
Antimicrobial therapy can prevent sepsis in pneumonia patients
Research sheds light on initial phase of infectious disease and potential for prevention of pneumococcal septicaemia.
Research suggests vapers are vulnerable to pneumonia
The vapor from e-cigarettes seems to help pneumonia-causing bacteria stick to the cells that line the airways, according to research published in the European Respiratory Journal.
Pneumonia: Treatment with vaccines instead of antibiotics
A properly functioning immune system is key to resolve bacterial pneumonia.
The end of pneumonia? New vaccine offers hope
A new vaccine under development provoked an immune response to 72 forms of the bacteria that's responsible for pneumonia, sepsis and meningitis.
Antibiotic therapy for nearly 1 in 4 adults with pneumonia does not work
Approximately one in four (22.1 percent) adults prescribed an antibiotic in an outpatient setting (such as a doctor's office) for community-acquired pneumonia does not respond to treatment, according to a new study presented at the 2017 American Thoracic Society International Conference.
Discovery may help patients beat deadly pneumonia
Researchers have identified a hormone that helps fight off a severe form of bacterial pneumonia, and that discovery may offer a simple way to help vulnerable patients.
More Pneumonia News and Pneumonia Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.